SCHEMBL12333422

SCHEMBL12333422

c1ccc(-n2c3ccccc3c3cc(N4c5ccccc5C(c5ccccc5)(c5ccccc5)c5ccccc54)ccc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ ATM Q13315 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ MAPK8 P45983 2/20 0.32
▸ KDR P35968 1/20 0.32
▸ MAPK9 P45984 1/20 0.32
▸ PTPN1 P18031 2/20 0.31
▸ KMT2A Q03164 2/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ CASP1 P29466 1/20 0.30
▸ CASP7 P55210 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ IL1R1 P14778 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21889079 0.96 KDM4E (0.44) KDM4EL3MBTL1ATMALDH1A1HDAC4
SCHEMBL14296782 0.93 KDM4E (0.40) KDM4EL3MBTL1ATMALDH1A1MAPK8
SCHEMBL21888241 0.92 KDM4E (0.45) KDM4EL3MBTL1ATMALDH1A1HDAC4
SCHEMBL21889078 0.92 KDM4E (0.42) KDM4EL3MBTL1ATMALDH1A1HDAC4
SCHEMBL20383383 0.91 KDM4E (0.36) KDM4EL3MBTL1ATM
SCHEMBL13143230 0.90 L3MBTL1 (0.50) KDM4EL3MBTL1ATMALDH1A1HDAC4
SCHEMBL18355542 0.89 KDM4E (0.46) KDM4EL3MBTL1ATMALDH1A1MAPK8
SCHEMBL3086844 0.89 L3MBTL1 (0.53) KDM4EL3MBTL1ATMALDH1A1HDAC4
SCHEMBL21888172 0.87 KDM4E (0.40) KDM4EL3MBTL1ATMHDAC4
SCHEMBL10309960 0.87 KDM4E (0.40) KDM4EL3MBTL1ATMHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11264575-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2022-03-01 — — US disclosed
US-10008673-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2018-06-26 — — US disclosed
US-10008673-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2018-06-26 — — US disclosed
US-20170155062-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-06-01 — — US disclosed
US-20170155062-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-06-01 — — US disclosed
US-20170155062-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-06-01 — — US disclosed
US-20120319052-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-12-20 — — US disclosed
US-20120319052-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-12-20 — — US disclosed
US-20120319052-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-12-20 — — US disclosed
WO-2011107186-A2 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-09-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11264575-B2 Compounds for electronic devices CYP2C19, CYP2C18, CYP1B1 KDM4E 3090/4885L3MBTL1 4058/4885ATM 4528/4885
US-20170155062-A1 COMPOUNDS FOR ELECTRONIC DEVICES CYP1B1, CYP1A1, CYP2E1 KDM4E 2681/4885L3MBTL1 3745/4885ATM 4337/4885
US-10008673-B2 Compounds for electronic devices CYP1B1, CYP1A1, CYP2E1 KDM4E 2681/4885L3MBTL1 3745/4885ATM 4337/4885
US-20120319052-A1 COMPOUNDS FOR ELECTRONIC DEVICES CYP1B1, CYP1A1, CYP2E1 KDM4E 2681/4885L3MBTL1 3745/4885ATM 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback